share

.Beta.-D-Ribo-Hexopyranose, 1,6-Anhydro-3-Deoxy-2-o-Methyl-4-o-(4-Methylcyclohexyl)Methyl- CAS NO 123919-21-1


Unit Price:

CAS No.:123919-21-1

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

.Beta.-D-Ribo-Hexopyranose, 1,6-Anhydro-3-Deoxy-2-o-Methyl-4-o-(4-Methylcyclohexyl)Methyl- is a specialized carbohydrate derivative, a modified anhydro sugar with a unique 4-O-(4-methylcyclohexyl)methyl substituent. This compound is valued for its role as a key chiral intermediate and building block in advanced organic synthesis, particularly for pharmaceuticals and fine chemicals. It is primarily sought by R&D chemists and process development scientists in the pharmaceutical, agrochemical, and specialty chemical industries for creating novel molecular architectures.

Application

  • Pharmaceutical Intermediate: Serves as a crucial chiral synthon for the development of novel active pharmaceutical ingredients (APIs), especially nucleoside analogs and carbohydrate-based therapeutics.
  • Agrochemical Synthesis: Used as a building block in the research and production of advanced herbicides, fungicides, and plant growth regulators with specific stereochemical requirements.
  • Glycochemistry Research: Acts as a protected or modified sugar derivative for studying glycosylation reactions, enzyme inhibitors, and carbohydrate-protein interactions.
  • Fine Chemical Production: Employed in the synthesis of complex natural products, flavors, fragrances, and other high-value specialty chemicals where precise stereochemistry is critical.
  • Material Science: Potential monomer or precursor for synthesizing novel polymers, dendrimers, or surfactants with specific biodegradable or biocompatible properties.

Basic Information

Item Details
Product Name .Beta.-D-Ribo-Hexopyranose, 1,6-Anhydro-3-Deoxy-2-o-Methyl-4-o-(4-Methylcyclohexyl)Methyl-
CAS No. 123919-21-1
Molecular Formula C15H26O5
Molecular Weight 286.37 g/mol
Synonyms 1,6-Anhydro-3-deoxy-2-O-methyl-4-O-[(4-methylcyclohexyl)methyl]-β-D-ribo-hexopyranose; 3-Deoxy-2-O-methyl-4-O-(4-methylcyclohexyl)methyl-1,6-anhydro-β-D-ribo-hexopyranose; Modified Anhydro-D-ribose Derivative; 4-O-(4-Methylcyclohexyl)methyl-1,6-anhydro-3-deoxy-2-O-methyl-β-D-ribo-hexopyranose; (4-Methylcyclohexyl)methyl Ether of 1,6-Anhydro-3-deoxy-2-O-methyl-β-D-ribo-hexopyranose
EINECS Contact for details

Quality Control

Every batch of this advanced intermediate is produced under strict quality management to ensure consistency and purity for sensitive synthetic applications. Our rigorous analytical protocols include HPLC, GC, NMR, and chiral analysis to verify identity, purity, and stereochemical integrity. A comprehensive Certificate of Analysis (COA) detailing all specifications is provided with each shipment. We support cGMP and ISO 9001 compliant manufacturing for pharmaceutical development needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). The compound may be hygroscopic (moisture-sensitive); keep the container tightly sealed under an inert atmosphere if specified. Keep away from strong oxidizing agents.

Specification

Item Specification
Appearance White to off-white crystalline powder
Identification (IR) Conforms to structure
Identification (NMR) Conforms to structure
Purity (HPLC) ≥ 97.0%
Chiral Purity ≥ 98.0% ee
Water Content (KF) ≤ 1.0%
Residue on Ignition ≤ 0.1%
Single Unknown Impurity (HPLC) ≤ 1.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.